Action JENBURPH6 JENBURKT PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jenburkt Pharmaceuticals Limited

Actions

JENBURPH6

INE354A01013

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:01:01 05/07/2024 		Varia. 5j. Varia. 1 janv.
877,6 INR -0,10 % Graphique intraday de Jenburkt Pharmaceuticals Limited +0,59 % +29,02 %
28/05 Jenburkt Pharmaceuticals Limited annonce des departs au conseil d'administration CI
28/05 Jenburkt Pharmaceuticals Limited annonce un dividende CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Jenburkt Pharmaceuticals Limited Announces Board Retirements
Jenburkt Pharmaceuticals Limited Announces Dividend
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as A Non-Executive and Independent Director
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as Non-Executive Independent Director
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended 31 March, 2023
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Jenburkt Pharmaceuticals Limited Approves Dividend
Tranche Update on Jenburkt Pharmaceuticals Limited's Equity Buyback Plan announced on December 1, 2022.
Jenburkt Pharmaceuticals Limited's Equity Buyback announced on December 1, 2022, has closed with repurchase of 176,078 shares, representing 3.84% for INR 114.24 million.
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Jenburkt Pharmaceuticals Limited announces an Equity Buyback for INR 116 million worth of its shares.
Jenburkt Pharmaceuticals Limited authorizes a Buyback Plan.
Jenburkt Pharmaceuticals Board to Consider Share Buyback
Jenburkt Pharmaceuticals Limited's Board intends to launch an Equity Buyback on December 1, 2022.
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action JENBURPH6
  4. Actualités Jenburkt Pharmaceuticals Limited
  5. Autres langues